ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




1. 4ÔÂ30ÈÕ£¬£¬£¬£¬NMPA¹ÙÍø×îй«Ê¾£¬£¬£¬£¬ÓÉ¿µ·½ÉúÎïÓëÕý´óÌìÇçÅäºÏÉ걨µÄ¿¹PD-1¿¹ÌåÅɰ²ÆÕÀûµ¥¿¹ÐÂ˳Ӧ֢ÉÏÊÐÉêÇëÒѾ»ñÅú¡£¡£¡£¡£¡£¡£¹ûÈ»ÐÅÏ¢ÏÔʾ£¬£¬£¬£¬¸Ã²úÆ·±¾´Î»ñÅúÓÃÓÚÈýÏßÖÎÁÆ×ªÒÆÐÔ±ÇÑʰ©¡£¡£¡£¡£¡£¡£
2. 4ÔÂ30ÈÕ£¬£¬£¬£¬NMPA¹ÙÍø×îй«Ê¾£¬£¬£¬£¬Î¢Ð¾ÉúÎïHDAC¿Ú·þÒÖÖÆ¼ÁÎ÷´ï±¾°·ÐÂ˳Ӧ֢ÉÏÊÐÉêÇëÒÑ»ñµÃÅú×¼£¬£¬£¬£¬±¾´Î»ñÅúµÄ˳Ӧ֢Ϊ£ºÁªºÏR-CHOP£¨ÀûÍ×Îôµ¥¿¹¡¢»·Á×õ£°·¡¢°¢Ã¹ËØ¡¢³¤´ºÐ¼îºÍÇ¿µÄËÉ£©ÓÃÓÚ¼ÈÍùδ¾ÖÎÁƵÄMYCºÍBCL2±í´ïÑôÐÔµÄÃÖÂþ´óBϸ°ûÁܰÍÁö£¨DLBCL£©»¼Õß¡£¡£¡£¡£¡£¡£
3. 4ÔÂ30ÈÕ£¬£¬£¬£¬°ÙʱÃÀÊ©¹ó±¦Ðû²¼£¬£¬£¬£¬Ð¡ÇòÂѰ×ÒÖÖÆ¼ÁÂê·¥¿Ì©½ºÄÒ»ñÖйú¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨NMPA£©Åú×¼ÉÏÊУ¬£¬£¬£¬ÓÃÓÚÖÎÁÆÅ¦Ô¼ÐÄÔàлá(NYHA)ÐĹ¦Ð§·Ö¼¶I1-III¼¶µÄ¹£×èÐԷʺñÐÍÐ¡£¡£¡£¡£¡£¡£¨HCM£©³ÉÈË»¼Õß¡£¡£¡£¡£¡£¡£
4. 4ÔÂ30ÈÕ£¬£¬£¬£¬ÒÚÌÚ¾°°ºÐû²¼Æä1ÀàÁ¢ÒìÒ©¶÷ÌæË¾ËûƬÐÂÒ©ÉÏÊÐÉêÇë»ñÖйú¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨NMPA£©ÕýʽÅú×¼£¬£¬£¬£¬Ë³Ó¦Ö¢ÎªÁªºÏ·¼Ï㻯øÒÖÖÆ¼ÁÓÃÓÚÖÎÁƼ¤ËØÊÜÌ壨HR£©ÑôÐÔ¡¢ÈËÀà±íƤÉú³¤Òò×ÓÊÜÌå2ÒõÐÔ£¨HER2-£©£¬£¬£¬£¬¾ÄÚÉøÍ¸ÖÎÁƸ´·¢»òÏ£ÍûµÄ¾Ö²¿ÍíÆÚ»ò×ªÒÆÐÔÈéÏÙ°©»¼Õß¡£¡£¡£¡£¡£¡£
1. ¿ËÈÕ£¬£¬£¬£¬ÖÐÃÀÈð¿µÓëÖøÃû½¥¶³Ö¢¿¹ÕùÕß¡¢¾©¶«¼¯ÍÅÔ¸±×ܲòÌÀÚÏÈÉú¿ª°ìµÄÓÐÊý²¡¹Ø°®Æ½Ì¨½¥ÓúÏàÖúÖ®¼ÒÅäºÏ½¨Éè½¥¶³Ö¢£¨ALS£©Ò©Î↑·¢ÁªºÏʵÑéÊÒ¡£¡£¡£¡£¡£¡£
1. 4 Ô 29 ÈÕ£¬£¬£¬£¬µ¤Âó¼¼Êõ´óѧµÈµ¥Î»µÄÑо¿Ö°Ô±ÔÚ Nature Microbiology ÔÓÖ¾½ÒÏþÁËÌâΪ Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood µÄÎÄÕ£¬£¬£¬£¬Ñо¿Ö¤ÊµÎú³¦µÀϸ¾ú×÷ΪÉú²úͨÓÃÊäѪ¡¢ÓÃѪµÄDZÔÚЧÓ㬣¬£¬£¬²¢ÓÐÍûÔÚδÀ´»º½â¡¸Ñª»Ä¡¹ÄÑÌâ¡£¡£¡£¡£¡£¡£
[1] Mathias Jensen, et al. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood. Nature Microbiology. (2024).
Ïà¹ØÐÂÎÅ